After pancreatic islet transplantation, insufficient blood supply is responsible for the loss of islet viability. The aim of our study was: 1) to determine the influence of vascular endothelial growth factor (VEGF) on the survival of encapsulated rat islets transplanted into healthy and diabetic mice and 2) to evaluate the metabolic efficiency of the VEGF-supplemented grafts. Twenty-four hours after culture, 50 rat islets immobilized into collagen in the presence of VEGF (100 ng/ml) and encapsulated (AN69 membrane, HOSPAL) were grafted in the peritoneal cavity of healthy or streptozotocin-induced diabetic mice (n = 6). Seven, 14, and 28 days after implantation, the encapsulation device and tissue surrounding the device were removed and the following parameters were analyzed: the number and the diameter of buds, the distance between devices and buds, the amount of cellular adhesion on the capsule surface, and the level of insulin secreted by encapsulated islet. For reversal of diabetes, 1000 rat islets encapsulated in the presence of VEGF were implanted in the peritoneal cavity of diabetic mice and fasting glycemia was analyzed. After 7 days of islet implantation in the absence of VEGF, the bud diameter was 16.1 ± 6.9 µm in diabetic mice and 34.4 ± 3.9 µm in healthy mice. However, the number of buds increased by a factor 2.5 in the presence of VEGF in both types of mice. Furthermore, when islets were transplanted in the presence of VEGF, the distance between the device and the buds was significantly decreased in both types of mice (p < 0.001) after 7, 14, and 28 days of islet implantation. Capsule analysis showed a decrease in cellular adhesion when the islets were encapsulated in the presence of VEGF. Insulin secretion of the islets was higher in the presence of VEGF compared with islets alone at all steps of the study. When 1000 rat islets were transplanted in the presence of VEGF, the glycemia level decreased to 6.2 ± 0.8 mmol/L after 3 days and remained stable until at least 28 days. In contrast, in the absence of VEGF, the initial decrease in the glucose level was rapidly followed by a relapse in hyperglycemia. In summary, VEGF increased the viability of engrafted encapsulated islets, increasing the duration of a normalized glycemia in diabetic mice following transplantation. Local adjunction of VEGF may therefore improve the clinical outcome of islet transplantation.
INTRODUCTION
They receive their blood supply from an afferent arteriole that branches into a glomerular-like network of microvessels (3, 37) . Islet capillaries are fenestrated, which Transplantation of pancreatic islets from healthy donors is potentially a very useful therapy for type I diabe-helps for the efficient release of secreted products into the bloodstream (3) . The process of isolating islets dis-tes by reducing hyper/hypoglycemia events for the improvement of the quality of life of diabetic subjects (2, rupts this specialized vasculature, thus impairing the survival of cells within the islet (30) . 26, 28, 29) . However, besides immune rejection, a significant obstacle to successful pancreatic islet transplanta-Several studies have demonstrated that a decreased blood supply may lead to the death of the β-cells in the tion is the inadequate vascularization of the graft during the first few days after transplantation (17) , which may core of cultured or transplanted islets (5, 21) . As vascular anastomosis is lost after islet transplantation, in contrast result in dysfunction and death of the islet tissue (4, 31) . In vivo, pancreatic islets are highly vascularized (19) .
to organ transplantation, revascularization of islets after 628 SIGRIST ET AL.
transplantation must be achieved to allow both long-ated the in vivo VEGF efficiency after transplantation in diabetic mice. term viability and functional outcome of the grafts. New blood vessel formation provides necessary nutrients and oxygen to the engrafted islets. Reestablishment of an ap-MATERIALS AND METHODS propriate microvascular supply is an essential prerequi-Pancreatic Islet Culture site for successful pancreatic islet transplantation. The Pancreatic islets were isolated from adult Wistar rats first step of angiogenesis (i.e., capillary sprouting formaweighting 220-250 g by standard collagenase (Sigma, tion and protrusion) can be detected as early as 2 days
St. Louis, MO) digestion (18) and hand-picked with the after islet transplantation, and the entire vascularization help of a dissecting microscope. After washing once process is completed within 10-14 days (21, 32) . Islets with Hank's solution, the islets were suspended in comtransplanted in vivo in diabetic organisms do not survive pleted culture medium composed of Medium 199 conas well as when placed into a normoglycemic environtaining 25 mM HEPES, 0.7 mM L-glutamine, and 11 ment (4, 12, 15) . The molecular mechanisms that initiate mM glucose (InVitrogen, Life Technologies, Paisley, and regulate the process of revascularization are incom-Scotland) supplemented with 10% heat-inactivated fetal pletely understood. Vascular endothelial growth factor calf serum (FCS, Eurobio, Les Ulis, France), 100 U/ml (VEGF) is known to be one of the most important angiopenicillin and 100 µl/ml streptomycin (Gibco), 40 µg/ml genic factors. It was first found as a potent inducer of gentamycin (Gibco), and 2.5 µg/ml fungizone (Gibco). microvascular hyperpermeability (27) and it stimulates Twenty-four hours after culture, 50 rat islets (for angiothe proliferation and maturation of vascular endothelial genesis, islet viability, and functionality studies) or 1000 cells (6) . VEGF is expressed in pancreatic islets (16, 25) .
rat islets (for fasting glycemia analysis) were immobi-Its secretion is increased in islet cells exposed to hyplized in a collagen gel supplemented or not with VEGF oxic conditions (33) . Hypoxia is likely to be encountered and encapsulated with a AN69 membrane as described during the first few days after islet implantation. In this below. respect, VEGF might represent a major stimulus for the growth of new blood vessels into the graft and the fenes-VEGF Preparation trated capillaries. Moreover, the presence of VEGF in normal islets suggests that it may be important also for Human recombinant VEGF (VEGF-165, R&D Systhe maintenance of normal islet vasculature (16, 34, 36) .
tem Inc, Minneapolis, MN) was used at a concentration However, tissue damage might be generated during the of 100 ng/ml. For this purpose, a stock VEGF solution preparation of islets in the view of transplantation, which (100 µg/ml) was made from lyophilized VEGF using may impair islet graft neovascularization. sterile PBS. The stock solution was then stored at −20°C The appearance of angiogenic markers is delayed in until further use and diluted into a working solution to islet grafts obtained from diabetic compared with northe appropriate concentration in the device (100 ng/ml). moglycemic donors (35). In the nondiabetic grafts, VEGF expression peaked the day after transplantation (34) Encapsulation of Rat Pancreatic Islets whereas in diabetic grafts this peak was found only at Pancreatic islets were encapsulated with the AN69 day 3 (35). This could be due to a more severe and longer membrane (HOSPAL, Meysieu, France) using the macstate of hypoxia, which results in delayed VEGF secreroencapsulation device developed in our laboratory and tion. In addition, a variety of studies have shown that described elsewhere (11). Briefly, this device is comislets transplanted into a hyperglycemic environment do posed of a support made of three poly-tetrafluoroethylless well than in an environment in which glucose conene rings, an artificial membrane forming the walls of centrations are controlled or normalized (1, 4, 9, 12, 14, 15) . the encapsulation chamber, and a collagen gel to immo-Oxygen consumption is known to be increased in β-cells bilize the islets. For islet encapsulation, 40 µl of this exposed to hyperglycemia (20) . It is thus likely that it suspension was poured into the chamber with a pipette would result in more hypoxic cell death. Treatments to and allowed to gel for 10 min at 37°C before sealing the enhance neovascularization in the transplanted islets of chamber with the membrane. diabetic patients might therefore improve the survival, function, and therapeutic efficiency of islet transplanta-Implantation of Encapsulated Islets tion.
In this view, along with the concept of protecting Fifty encapsulated islets immobilized into collagen and supplemented or not with VEGF (100 ng/ml) were pancreatic islets with an encapsulation device to limit immune rejection, we have investigated the influence of implanted in the peritoneal cavity of anesthetized Swiss mice weighting 20-30 g by means of a small lapa-VEGF on the survival of encapsulated rat islets after transplantation in normal and diabetic mice and evalu-rotomy.
Animals buffer solution (pH 7.4), dehydrated through a graded sequence of ethanol solutions, stained with hematoxylin-Mice were divided into five groups: mice implanted eosin, and finally examined by phase contrast microswith empty devices or devices containing collagen alone copy. The light microscopic examination allowed us to or collagen supplemented with VEGF, or devices conidentify the different kinds of cells adhering to the memtaining islets immobilized into collagen with or without brane surface and to evaluate the percentage of cell-VEGF. To study the angiogenesis of the granulation tiscovered membranes. sue, the surface membrane of the encapsulation devices, the morphological aspects, and the functional activity of Morphological Aspects and Functional Activity encapsulated islets, the mice were killed and devices of Encapsulated Islet Cells with surrounding tissue were removed. The time points
The encapsulated islets were removed from the deof the study were 7, 14, and 28 days after implantation.
vice and examined by phase contrast microscopy 7, 14, Histological Evaluation of Angiogenesis and 28 days after implantation. The glucose-stimulated insulin secretion of the islets was determined by static Six mice in each group were killed 7, 14, and 28 days incubation after recuperation of the islets in the encapsuafter implantation and omenta surrounding the encapsulation device. Islets were plated in a 24-well plate (50 lation device were removed. After 24 h of fixation in islets/well). After a first incubation step in 1 ml Krebs formol buffer 4%, the tissues were dehydrated in graded Ringer solution containing 0.5% FCS and 0.8 g/L gluethanol and embedded in paraffin. Five to 10 sections cose, islets were stimulated with 1 ml Krebs Ringer so-(5 µm) were cut (24). Blood vessels were examined after lution containing 0.5% FCS and 4 g/L glucose. Finally, staining the sections with hematoxylin and eosin. Three the islets were transferred into 1 ml Krebs Ringer soluparameters were measured on these sections: the numtion containing 0.5% FCS and 0.8 g/L glucose. Each ber, the diameter of the buds, and the distance between incubation step was carried out at 37°C for 90 min folthe device and the bud. lowed by extensive washes after supernatant recovery Blood vessels were examined along the membrane for the measurement of insulin concentration determinasurface using a phase contrast microscope (magnification by RIA (CIS bio, Gif-sur-Yvette, France). Insulin tion ×40). Bud diameters and the distance between the release was expressed as µU/ml/well and was compared device and buds were measured using an ocular micromto freshly isolated islets. eter mounted on the phase contrast microscope. On each slide, 20 fields were quantified by two independent ex-Fasting Blood Glucose aminers.
Diabetes was induced in 30-40-g male Swiss mice Analysis of the Macroencapsulation Devices by IP injection of 200 mg/kg streptozotocin (Sigma). To confirm whether the mice were indeed diabetic, the gly-Three mice in each group at each step of the study cemia level of tail blood was measured 4 weeks after were killed and the macroencapsulation devices removed.
injection. Mice with levels above 20 mmol/L on 2 suc-The implantation area of the device was examined for cessive days were considered as diabetic. The devices the recipient surrounding tissue necrosis and/or inflamcontaining 1000 rat islets supplemented or not with mation. The device was then dismantled to analyze the VEGF were implanted in the peritoneal cavity of six artificial membrane. The rings and membranes were air anesthetized recipients in each group. The glucose level dried, mounted on aluminium stubs, coated with gold, of the recipients was measured daily after overnight fastand stored in a dry atmosphere before examination uning using a Prestige glucometer (Chronolyss, Le Raincy, der a Philips 501B scanning electron microscope.
France). Their structure and the cells stuck to the membrane were analyzed and compared with implanted control de-Statistical Analysis vices.
The presence of macrophages to the membrane sur-Data are given as mean and standard deviation error of the mean. After analysis for normal distribution and face was evaluated by means of a phagocytosis test while other kinds of cells were identified after a hematoxylin-equal variances, statistical procedures include a one-way analysis of variance followed by an appropriate post hoc eosin stain. Briefly, membranes from both empty and islet-containing devices were incubated in 1 ml of MEM test for comparisons between the groups (ANOVA). Subsequently, comparison between groups was performed in the presence of 100 µl of Saccharomyces cerevisae yeast suspension (10 8 cells/ml) stained with Coomassie using the Student-Newman-Keuls method. Differences were considered significant at p < 0.05. blue. After a 3-h incubation, membranes were washed and the cells adhering to the membrane surface were As for fasting blood glucose, the comparisons between islets encapsulated alone or in the presence of fixed in a 2% glutaraldehyde/0.2 M sodium cacodylate VEGF were performed using Student's test. Statistical tween the VEGF unsupplemented collagen-containing and the islet-containing devices. In all the groups, the significance was set at p < 0.05.
number of buds increased between 7 and 14 days after implantation. Approximately the same number of buds RESULTS was found after 14 and 28 days (data not shown).
Histological Quantification of Angiogenesis
Seven days after implantation, the distance between the device and the buds (Fig. 1C, D) was significantly Seven days after implantation, the number of buds on tissue surrounding collagen-containing devices was lower in diabetic mice when devices contained VEGF compared with collagen-containing devices (18.9 ± 2.1 higher in control mice (14.2 ± 2.5) than in diabetic mice (6.4 ± 2.2) ( Fig. 1A, B ). Addition of VEGF in the device vs. 45.1 ± 1.1 µm, n = 6, p < 0.01). Similar results were obtained 14 days after implantation. While the distance induced an increase in the number of buds in control (24.1 ± 2.5 vs. 15.6 ± 3.2, p < 0.05) and in diabetic mice between the device and the buds was higher when islets were encapsulated alone, the presence of VEGF in islet-(15.6 ± 3.2 vs. 6.4 ± 2.2, p < 0.01). Similar results were obtained when VEGF-supplemented islet devices were containing devices significantly shortened this distance (36.8 ± 6.8 vs. 21.8 ± 4.5 µm in control mice and 40.1 ± compared with unsupplemented islet devices. Angiogenesis was not only induced by islets, because no signifi-3.6 vs. 27.2 ± 1.7 µm in diabetic mice, n = 6, p < 0.01). Fourteen days after implantation, the distance in control cant difference in the number of buds was observed be- 
conditions (collagen alone) was similar in healthy and
(data not shown) revealed that the cells adhering to the membrane surface were mainly macrophages. The pres-in diabetic mice.
The diameter of buds ( Fig. 2 ) was significantly in-ence of macrophages was reduced when islets were supplemented with VEGF compared with islets alone. creased in the presence of VEGF compared with collagen alone: 68.5 ± 4.2 vs. 25.1 ± 6.2 µm in control mice Viability and Functionality of Islets and 79.3 ± 1.3 vs. 34.5 ± 4.0 µm in diabetic mice 7 days postimplantation (p < 0.01) (histogram not shown). This
The morphological aspect of most of the islets encapincrease was emphasized 14 days after implantation: sulated with VEGF seemed preserved 14 days after im-112.3 ± 3.5 vs. 50.2 ± 8.9 µm in control mice and 108.2 ± plantation, with a round structure and no central necrosis 6.9 vs. 58.5 ± 7.01 µm in diabetic mice (p < 0.001) (data ( Fig. 4A ) and rare islet disruption. not shown). The diameter of buds was comparable in Islets encapsulated alone displayed lysis (Fig. 4B ). control and in diabetic mice (Fig. 2) .
After 28 days, no intact islets could be found anymore in these devices. The islets did not appear as round structures Analysis of Macroencapsulation Devices bound by an intact outlet but were almost disintegrated. Similar results were obtained in control and diabetic mice. Devices were collected 7 and 14 days after implantation. It seemed that implantation areas remained intact As shown by Figure 5 , after incubation of the implanted islets with 0.8 and 4 g/L of glucose, the insulin and that macroscopic aspect of the devices was preserved. However, macroscopic appearance of the tissues secretion increased from 329.2 ± 22.5 to 849.6 ± 21.9 µU/ml/100 islets for encapsulated islets and from 668 ± around the device revealed an increase of vascularization when the devices contained VEGF. Scanning elec-48.6 to 1467.2 ± 51.7 µU/ml/100 islets for VEGF-encapsulated islets after 7 days of implantation. In the absence tron microscopy examination showed a decreased cellular adhesion when islets were encapsulated with VEGF of VEGF, the insulin secretion decreased 14 days after implantation while the secretion was preserved in VEGF-compared with islets encapsulated alone both in control (Fig. 3A, B ) and diabetic mice (data not shown). A cyto-supplemented islets. Similar results were obtained 28 days after implantation. logical study in control (Fig. 3C, D) and diabetic mice 
Fasting Blood Glucose DISCUSSION
Our study demonstrates that the presence of VEGF The fasting glycemia level of diabetic mice (Fig. 6 ) was normalized 3 days after implantation of devices within the encapsulation devices is able to stimulate angiogenesis and reduce macrophage adhesion at the mem-containing islets alone or VEGF-supplemented islets (9.66 ± 2.31 and 7.43 ± 2.31 mmol/L, respectively). Nor-brane surface. Moreover, VEGF increased the viability of the grafted islets and prolonged the normal glycemia mal fasting glycemia levels were seen 1 week after implantation in mice implanted with VEGF-supplemented in diabetic mice after transplantation. Revascularization of islet grafts after transplantation devices whereas it was increased in the diabetic mice implanted with VEGF-devoid islets (7.31 ± 0.93 vs. 15.51 ± is an important process for long-term graft viability and clinical benefit. The formation of new blood vessels im-3.35).
Normal glycemia levels were preserved in the pres-proves the provision of nutrients and oxygen to the grafts and the release into the blood stream of the newly gener-ence of VEGF until at least 28 days after implantation (data not shown). In contrast, the glycemia of mice im-ated insulin. VEGF is a major factor initiating the growth of new blood vessels into the graft and the devel-planted with islets alone raised up to 149.4 ± 1.7 after 14 days of implantation and all the mice died before day opment of their fenestrations. However, tissue damage during islet isolation might reduce the expression of 28 after implantation. that it is possible to restore neovascularization with VEGF (23). Our study confirmed this observation in our engraftment conditions: although the number of buds was reduced in diabetic mice compared with control mice, addition of VEGF increased the neovascularization of tissues surrounding the device in both healthy and diseased animals.
The revascularization of transplanted islets, which has been well characterized, occurs over a period of 3-14 days, which may depend on increased secretion of VEGF by ischemic islets and upregulation of VEGF receptors in the adjacent host tissue (8,21). In the nondiabetic VEGF expression in diabetic mice.
The process of revascularization of transplanted islets is of crucial importance for the preservation of function VEGF to some extent and consequently affect the neoduring the early phase of the posttransplantation period. vascularization of islet grafts. Immediately after trans-In our study, addition of VEGF in the islet-containing plantation, the islets are supplied with oxygen and nutridevices preserves islet viability and functionality in conents solely by diffusion from the surrounding tissues. To trol and diabetic mice for at least 28 days following iminvestigate the effect of VEGF on angiogenesis, we have plantation. The increased vascularity of the omentum used devices that protect xenogeneic islets from immune probably enhanced the diffusion of oxygen and nutrients rejection while allowing the passage of VEGF and profrom outside of the device and improved islet viability. teins produced by the islets (11). Implanted in the perito-However, while the preservation of islet viability was neal cavity, such a device preserves the functional activprobably due to the increased vascularization, we do not ity of the encapsulated islets (11). In our study, we showed forget the part of the VEGF effect on antiapoptotic functhat the presence of VEGF in an islet-containing encaption (10,13) or the β-cell proliferation-inducing capacity sulation device increased angiogenesis of tissue surof VEGF (22) or the immunomodulatory properties of rounding the device in both control and diabetic mice.
VEGF described by the inhibition of functional matura-Several studies have demonstrated that neovascularization of dendritic cells (7). This is however unlikely as tion is impaired in diabetic mice and that the impairment the incubation of VEGF in cultured islets had no effect in new blood vessel formation results from reduced exon both their viability and functionality (data not shown). pression of VEGF (23,35). However, the authors show Our previous study in which rat islets were placed into encapsulated membrane devices showed that murine macrophages were attracted to the surface of the AN69 membrane after transplantation because no cellular adhesion was observed in control devices (11). Moreover, the presence of VEGF in the encapsulation devices caused a reduction of this chemotactic activity. Isletcontaining devices in the presence of VEGF decreased this macrophage attraction. Our previous study has also shown that the implanted islets changed their morphology and functions concurrently with the cellular reaction (11) because this reaction was involved in islet necrosis. Reduction of macrophage adhesion in the presence of VEGF was probably due to the preservation of the islet 
